Brief: Pixium Vision Announces First Patient Successful Implantation In Prima System Pivotal Trial Primavera

Pixium Vision SA

07/04/2021 07:19

April 7 (Reuters) - Pixium Vision SA  ALPIX.PA :
    * PIXIUM VISION ANNOUNCES FIRST PATIENT SUCCESSFUL
IMPLANTATION IN
PRIMA SYSTEM PIVOTAL TRIAL PRIMAVERA
    * STUDY IS LAST CLINICAL STEP BEFORE SEEKING MARKET APPROVAL
IN
EUROPE IN DRY AMD
    * EXPECTS TO REPORT 36-MONTH DATA FROM FRENCH FEASIBILITY
STUDY BY
END 2021 / BEGINNING 2022, AND CONTINUES CLINICAL DEVELOPMENT IN
US
    * TOTAL OF 38 PATIENTS WILL BE ENROLLED IN PRIMAVERA, AN
OPEN
LABEL, BASELINE-CONTROLLED, NONRANDOMIZED, MULTICENTER,
PROSPECTIVE, SINGLE-ARM CONFIRMATORY TRIAL
    * BIONIC VISION PRIMA SYSTEM HAS SHOWN EXCELLENT RESULTS IN
IMPROVING VISION

Source text for Eikon:  ID:nGNEbcc47h 
Further company coverage:  ALPIX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))